Menu
Recruiting NCT06932484

Delta Variation to Guide Hemodynamic Optimization

No phase Interventional Hemodynamic MAP Stability

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: parameters.
Who it may be relevant to
Registry conditions: Hemodynamic MAP Stability. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A NEW APPROACH IN THE MANAGEMENT OF INTRAOPERATIVE ARTERIAL HYPOTENSION BASED ON DELTA VARIATION OF HEMODYNAMIC PARAMETERS: A RANDOMISED CLINICAL TRIAL

Overview

intraoperative hemodynamic optimization will be based on the percentage of variation of the parameters

Interventions

  • Procedure parameters
    during surgery hemodynamic will be optimized based on percentage variation of different variables

Primary outcome measures

  • time weighted average of mean arterial pressure [Time frame: the end of surgery]

Eligibility criteria

Inclusion Criteria: All patients > 18 years old scheduled for major abdominal

Exclusion criteria

Body Mass Index > 35 kg/m2 Pregnancy Refusal to sign written informed consent Urgent and/or emergency surgery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Italy · 1 center
  • Fondazione Policlinico Universitario Agostino Gemelli — Rome

Identifiers

NCT: NCT06932484 · 7428

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗